Catalio Capital Management, LP
CIK 1958125 · Holdings on Jun 30, 2025 · First reported Aug 14, 2025
Top ten holdings
Q2 2025- LLY8.81%
- BBIO8.40%
- SLNO7.20%
- ASND6.51%
- ISRG6.46%
- EW6.41%
- GILD5.27%
- BSX5.16%
- CYTK4.17%
- SNDX4.13%
Share classes counted separately62.52%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- SLNOWeight increased · +4.35 pp2.85% → 7.20%Shares +248.98K (+154.68%)
- LLYWeight increased · +3.96 pp4.85% → 8.81%Shares +30.23K (+127.67%)
- ADPTWeight increased · +2.28 pp1.13% → 3.41%Shares +784.81K (+128.31%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | LLYELI LILLY & CO View history and evidence | $42.03M | 8.81% | 53.92K shares | 4.85% → 8.81%+3.96 pp +30.23K (+127.67%) | Added | ↗▾ |
| 02 | BBIOBRIDGEBIO PHARMA INC View history and evidence | $40.06M | 8.40% | 927.71K shares | 8.25% → 8.40%+0.15 pp -35.17K (-3.65%) | Reduced | ↗▾ |
| 03 | SLNOSOLENO THERAPEUTICS INC View history and evidence | $34.35M | 7.20% | 409.94K shares | 2.85% → 7.20%+4.35 pp +248.98K (+154.68%) | Added | ↗▾ |
| 04 | ASNDASCENDIS PHARMA A/SSPONSORED ADR View history and evidence | $31.06M | 6.51% | 179.93K shares | 7.56% → 6.51%-1.05 pp -15.60K (-7.98%) | Reduced | ↗▾ |
| 05 | ISRGINTUITIVE SURGICAL INCCOM NEW View history and evidence | $30.80M | 6.46% | 56.67K shares | 4.48% → 6.46%+1.98 pp +20.18K (+55.28%) | Added | ↗▾ |
| 06 | EWEDWARDS LIFESCIENCES CORP View history and evidence | $30.57M | 6.41% | 390.93K shares | 7.83% → 6.41%-1.42 pp -44.66K (-10.25%) | Reduced | ↗▾ |
| 07 | GILDGILEAD SCIENCES INC View history and evidence | $25.15M | 5.27% | 226.88K shares | Prior unavailable +226.88K | New | ↗▾ |
| 08 | BSXBOSTON SCIENTIFIC CORP View history and evidence | $24.60M | 5.16% | 229.05K shares | Prior unavailable +229.05K | New | ↗▾ |
| 09 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $19.87M | 4.17% | 601.44K shares | 5.84% → 4.17%-1.67 pp +15.63K (+2.67%) | Added | ↗▾ |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $19.71M | 4.13% | 2.10M shares | 5.28% → 4.13%-1.15 pp +370.81K (+21.39%) | Added | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 10
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| BDX BECTON DICKINSON AND CO | Non-derivative | -203,965 | -$46.72M | SEC filing ↗ | SEC filing ↗ |
| SWTX SPRINGWORKS THERAPEUTICS INC | Non-derivative | -758,533 | -$33.47M | SEC filing ↗ | SEC filing ↗ |
| VCYT VERACYTE INC | Non-derivative | -762,225 | -$22.60M | SEC filing ↗ | SEC filing ↗ |
3 / 10 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1958125 · Period 2025-06-30
Data loaded 2026-09-23 · First reported 2025-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 476910569
}Research all 40 reported holdings.
This page includes 30 of 40 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 40 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1958125","quarter":"2025Q2","page_size":100}
get_institutional_manager_history
{"cik":"1958125","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.